KW

Kwangdong Healthbio Co., Ltd.

086220 | KO

Overview

Corporate Details

ISIN(s):
KR7086220001
LEI:
Country:
South Korea
Address:
충청북도 청원군 오창읍 양청송대길 39(송대리), 오창읍
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

No description available.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-04 00:00
Report Publication Announcement
기업설명회(IR)개최결과
Korean 6.7 KB
2025-05-21 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.1 KB
2025-03-25 00:00
AGM Information
정기주주총회결과
Korean 15.2 KB
2025-03-17 00:00
Audit Report / Information
감사보고서제출
Korean 9.6 KB
2025-03-17 00:00
Annual / Quarterly Financial Statement
사업보고서 (2024.12)
Korean 436.1 KB
2025-03-10 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 114.1 KB
2025-02-25 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 26.1 KB
2025-02-25 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 25.1 KB
2025-02-25 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 8.4 KB
2025-02-25 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 28.6 KB
2024-12-11 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.4 KB
2024-10-30 00:00
Report Publication Announcement
기업설명회(IR)개최결과
Korean 6.7 KB
2024-10-14 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.0 KB
2024-08-20 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 53.3 KB
2024-08-19 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 53.6 KB

Automate Your Workflow. Get a real-time feed of all Kwangdong Healthbio Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Kwangdong Healthbio Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Kwangdong Healthbio Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ELUTIA INC. Logo
Develops drug-eluting biologics to reduce complications from medical implants.
United States of America
ELUT
Emergent BioSolutions Inc. Logo
Develops and manufactures medical countermeasures for public health and national security threats.
United States of America
EBS
ENANTA PHARMACEUTICALS INC Logo
Developing novel small molecule drugs for virology (HCV, RSV) and immunological diseases.
United States of America
ENTA
Enervit Logo
Produces sports nutrition & wellness supplements for athletes and active lifestyles.
Italy
ENV
enGene Holdings Inc. Logo
Developing non-viral, locally administered gene therapies for rare genetic conditions.
United States of America
ENGN
Enliven Therapeutics, Inc. Logo
A clinical-stage biopharma developing kinase inhibitors for precision oncology cancer treatment.
United States of America
ELVN
Enlivex Therapeutics Ltd. Logo
Developing cell therapy that reprograms macrophages to treat immune hyper-responses like sepsis.
United States of America
ENLV
Enlivex Therapeutics Ltd. Logo
Developing cell therapy to restore immune balance for inflammatory diseases like sepsis.
Israel
ENLV
Enorama Pharma AB Logo
Develops & makes consumer nicotine products & medicated gums, offering private label solutions.
Sweden
ERMA
Ensol Biosciences Inc. Logo
Develops AI-discovered peptide drugs for cancer, osteoarthritis, and Alzheimer's disease.
South Korea
140610

Talk to a Data Expert

Have a question? We'll get back to you promptly.